Keywords: Rhythm Pharma, Financing, RM-131, Pfizer, Ipsen

Rhythm expands Series B financing to $33 Million, adding Pfizer Ventures as an investor

Article | 27 November 2012

Boston, USA-based biotech firm Rhythm Pharmaceuticals says it has raised an additional $8 million to complete a $33 million Series B financing. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Pfizer

Ipsen

Rhythm Pharmaceuticals

Go to company listing

Related Drugs

RM-131

Go to drug listing